[5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol
C20H25N5O — CID 156621895
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol
[5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol (PubChem CID 156621895) has the molecular formula C20H25N5O and a molecular weight of 351.45 g/mol. Its IUPAC name is [5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol.
Molecular Properties
| Compound Name | [5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol |
|---|---|
| PubChem CID | 156621895 |
| Molecular Formula | C20H25N5O |
| Molecular Weight | 351.45 g/mol |
| Exact Mass | 351.21 |
| IUPAC Name | [5-amino-2-[(2S,6R)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]imidazo[1,2-a]pyridin-3-yl]methanol |
| SMILES | Cc1cccnc1[C@H]1CCC[C@@H](c2nc3cccc(N)n3c2CO)N1C |
| InChI | InChI=1S/C20H25N5O/c1-13-6-5-11-22-19(13)14-7-3-8-15(24(14)2)20-16(12-26)25-17(21)9-4-10-18(25)23-20/h4-6,9-11,14-15,26H,3,7-8,12,21H2,1-2H3/t14-,15+/m1/s1 |
| InChIKey | ZGNSIJHHOGWDBT-CABCVRRESA-N |
| XLogP | 3.01 |
| TPSA | 79.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 351.45 |
| LogP ≤ 5 | 3.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156621895 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.